There are still lots of open positions. Let's find the one that's right for you.
Within Pfizer's Real World Evidence (RWE) Platform, the Integrated Evidence Plan (IEP) Success team operates as an internal advisory and production function. This team expertly engages with cross-functional category and asset-aligned teams to oversee and facilitate the creation and routine refresh of individual IEPs for prioritized assets and programs. The IEP is a critical tool in the evidence planning and execution process, establishing a living, tactical plan for evidence generation teams to follow, ensuring that more complete evidence packages are available to support regulatory, launch, and post-launch strategy. The IEP Director is a member of the IEP Success team with direct responsibility for driving process execution in the initial creation and subsequent management and refresh of an IEP for each assigned priority asset or program. This role requires close partnerships with the respective RWE Leads for the asset. The IEP Director draws from robust knowledge of the drug development lifecycle to navigate the cross-functional asset team through the IEP process, facilitating discussions and negotiating decisions at each step relevant to the given asset's strategy and lifecycle stage. They must understand the asset or program science to curate and synthesize information from available sources, such as Target Product Profiles (TPP), Clinical Development Plans (CDP), and literature reviews, into IEP materials and discussions, establishing credibility with the asset team. Following the initial IEP creation, the IEP Director monitors the progression of the IEP over the course of the asset's lifecycle to ensure that approved, funded tactics are executed according to plan. They also monitor for new data or information that may trigger a review or refresh of the IEP at least annually. As the front line working directly with cross-functional asset teams across a variety of programs, the IEP Director plays a critical role in identifying key learnings for process improvements and efficiencies, bringing recommendations to the central IEP team in support of a continuous improvement cycle for the IEP program overall.